Newsroom
To Get in Touch with DLC:
Media (@) Diabetes Leadership (DOT) org
Hot Topics
Letter
DLC and DPAC issue joint statement on Tennessee decision to reject legislation that would cap insulin costs
Read MoreRelease
Victory For Patients Reiterated - Court Makes it Clear: Rule Requiring Copay Assistance to Count Now in Effect
Read MoreRelease
JDRF and DLC Joint Statement on Medicare Local Coverage Determination on Glucose Monitors
Read MoreIn The News
Pulse: Extreme Heat in High Risk Populations
Politico
FTC votes against probing the controversial practices of PBMs
Stat News
Capitol Report: Insulin Pricing Policy Briefing
NTD
Less Talk, More Action on Diabetes
Real Clear Health
Headed Away to School? Here’s What Students With Health Issues Need to Know
Kaiser Health News
FTC Launches Inquiry into PBM Industry
FTC Policy and Medicine
Statements and Letters
Fast Facts
Policy Recommendations to Improve U.S. Health Care
Patient costs for medicines, equipment and supplies should reflect all discounts and rebates negotiated or mandated across the supply chain, just like other health care products and services. National level rebate reform is a critical step to help patients afford their medicines and confront perverse financial incentives in the current system.
Download Our Consensus Statement